Sg Americas Securities, LLC Anavex Life Sciences Corp. Transaction History

Sg Americas Securities, LLC

$30.5 Billion
Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 25,242 shares of AVXL stock, worth $225,915. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,242

Previous 34,844 27.56%

Holding current value

$225,915

Previous $374,000 41.98%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$7.85 - $13.46 $75,375 - $129,242	-9,602 Reduced 27.56%	25,242 $217,000
Q4 2024 Jan 17, 2025	BUY	$5.11 - $12.56 $36,475 - $89,653	7,138 Added 25.76%	34,844 $374,000
Q3 2024 Oct 03, 2024	BUY	$4.11 - $7.04 $58,657 - $100,474	14,272 Added 106.24%	27,706 $157,000
Q2 2024 Jul 12, 2024	BUY	$3.39 - $5.02 $45,541 - $67,438	13,434 New	13,434 $57,000
Q4 2023 Jan 12, 2024	BUY	$5.04 - $9.95 $192,301 - $379,642	38,155 Added 14.16%	307,568 $2.86 Million
Q3 2023 Oct 13, 2023	BUY	$6.55 - $9.37 $1.76 Million - $2.52 Million	269,413 New	269,413 $1.77 Million
Q1 2023 Apr 28, 2023	BUY	$8.32 - $11.75 $119,050 - $168,130	14,309 Added 83.81%	31,382 $269,000
Q4 2022 Feb 02, 2023	BUY	$7.65 - $14.43 $20,004 - $37,734	2,615 Added 18.09%	17,073 $158,000
Q3 2022 Oct 31, 2022	SELL	$8.9 - $12.86 $169,420 - $244,802	-19,036 Reduced 56.83%	14,458 $149,000
Q2 2022 Jul 29, 2022	BUY	$7.31 - $12.84 $244,841 - $430,062	33,494 New	33,494 $335,000
Q1 2022 Apr 29, 2022	SELL	$9.74 - $17.69 $122,237 - $222,009	-12,550 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$16.88 - $23.31 $213,633 - $295,011	-12,656 Reduced 50.21%	12,550 $218,000
Q3 2021 Nov 01, 2021	BUY	$16.82 - $25.75 $423,964 - $649,054	25,206 New	25,206 $452,000
Q2 2021 Aug 12, 2021	SELL	$10.16 - $28.86 $105,857 - $300,692	-10,419 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$5.17 - $16.13 $53,866 - $168,058	10,419 New	10,419 $156,000
Q1 2018 May 03, 2018	SELL	$2.32 - $3.44 $49,622 - $73,578	-21,389 Closed	0 $0
Q4 2017 Jan 24, 2018	BUY	$3.12 - $4.94 $66,733 - $105,661	21,389	21,389 $69,000

Others Institutions Holding AVXL

# of Institutions

189

Shares Held

29.2M

Call Options Held

894K

Put Options Held

821K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $698M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Anavex Life Sciences Corp. Transaction History